日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial

卡瑞利珠单抗联合 CAPOX 方案（以卡瑞利珠单抗为基础的维持治疗）与单用 CAPOX 方案作为胃癌或胃食管交界处腺癌一线治疗的疗效比较：一项随机 3 期试验

期刊:Bmj-British Medical Journal
影响因子:42.7
doi:10.1136/bmj-2025-086115
Peng, Zhi; Zhang, Yanqiao; Xu, Huiting; Yang, Yan; Yang, Mudan; Zhang, Mingjun; Cheng, Ying; Chen, Xiaobing; Pan, Yueyin; Wang, Feng; Li, Qingshan; Xu, Nong; Liu, Likun; Gu, Kangsheng; Xiao, Juxiang; Zhang, Ruixing; Zhao, Qun; Chen, Jian; Lin, Lizhu; Chen, Yigui; Deng, Yanhong; Cai, Shirong; Bai, Bin; Wang, Yiru; Shen, Lin
胃癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Hepatotoxicity induced by polylactic acid microplastics: The mediating role of gut microbiota and uric acid metabolism

聚乳酸微塑料诱导的肝毒性：肠道菌群和尿酸代谢的介导作用

期刊:Journal of Advanced Research
影响因子:13
doi:10.1016/j.jare.2025.08.055
Deng, Yanhong; Li, Zhiming; Huang, Yuji; Zhong, Yizhou; Qiu, Aiqin; Chen, Xiaoqing; Huang, Xiyun; Yang, Xiaohong; Feng, Yu; Bai, Ruobing; Fan, Bingchi; Xian, Hongyi; Li, Hao; Chen, Da; Liang, Boxuan; Huang, Zhenlie
微生物学
肠道菌群
毒理研究
代谢
发表日期：2026
文献求助 收藏

Validation of the Ectropion Severity Score in Epidermal Differentiation Disorders

表皮分化障碍中睑外翻严重程度评分的验证

期刊:Jama Dermatology
影响因子:11
doi:10.1001/jamadermatol.2025.6166
Echeandia-Francis, Caroline; Luo, Angela J; Jiang, Xingyuan; Ellis, Katharine T; Mani, Mitra V; Chen, Tiffany X; Gan, Geliang; Deng, Yanhong; Choate, Keith A
发表日期：2026
文献求助 收藏

Cathepsin-D-mediated MHC class I degradation contributes to immune evasion in colorectal cancer.

组织蛋白酶 D 介导的 MHC I 类降解有助于结直肠癌的免疫逃逸。

期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2025.102534
Zhan Weixiang, Fu Yang, Liu Yina, Cai Runkai, Bai Fan, Guo Chenxu, Cheng Yi, Wu Zehua, Qin Ge, Xie Yuqian, Zhang Jianwei, Deng Yanhong
肿瘤
肠癌
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

Clinical Pharmacists, Medications, and Contingency Management for Targeting Smoking in HIV Clinics: A Randomized Clinical Trial

临床药师、药物和应急管理在艾滋病诊所戒烟中的应用：一项随机临床试验

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2025.60593
Edelman, E Jennifer; Deng, Yanhong; Dziura, James; Nahum-Shani, Inbal; Weiss, June-Marie; Aoun-Barakat, Lydia; Bold, Krysten W; Harsono, Dini; Mistler, Colleen; Payne, Erika; Aiudi, Sherry; Sigel, Keith M; Yager, Jessica E; Ledgerwood, David M; Bernstein, Steven L
发表日期：2026
文献求助 收藏

Stevioside curbs Streptococcus pneumoniae infection via inhibiting capsule biosynthesis

甜菊苷通过抑制荚膜生物合成来抑制肺炎链球菌感染。

期刊:Communications Biology
影响因子:5.1
doi:10.1038/s42003-025-09230-1
Gu, Sanwei; Zhang, Jian; Fan, Xiaoye; Liu, Huacan; Yang, Huaizhi; Ding, Ying; Deng, Xuming; Song, Lei; Deng, Yanhong; Wang, Tingting
肺炎
炎症/感染
发表日期：2026
文献求助 收藏

Yoga intervention on the fatigue-pain-sleep disturbance symptom cluster for breast cancer patients receiving adjuvant chemotherapy: a pilot randomized controlled trial

瑜伽干预对接受辅助化疗的乳腺癌患者疲劳-疼痛-睡眠障碍症状群的影响：一项初步随机对照试验

期刊:BMC Complementary Medicine and Therapies
影响因子:3.4
doi:10.1186/s12906-026-05285-7
Qi, Yishu; Cao, Ying; Deng, Yanhong; Ma, Xing; Chan, Dorothy Ngo Sheung; Wong, Cho Lee; Guo, Yao
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Impact of multidisciplinary steatotic liver disease management on bariatric surgery referral and clinical outcomes: A retrospective cohort study

多学科脂肪肝疾病管理对减重手术转诊和临床结果的影响：一项回顾性队列研究

期刊:World Journal of Hepatology
影响因子:2.5
doi:10.4254/wjh.v18.i1.113753
Schwartz, Andrew W; Park, Emily Y; Ilagan-Ying, Ysabel C; Zimmerman, Zoe E; Bollinger, Bryan; Ying, Lee D; Deng, Yanhong D; Duffy, Andrew J; Morton, John M; Mehal, Wajahat Z; Do, Albert; Banini, Bubu A
脂肪肝
代谢
发表日期：2026
文献求助 收藏

Efficacy and safety of IBI351 (fulzerasib) monotherapy in KRAS(G12C) inhibitor-naïve Chinese patients with KRAS(G12C)-mutated metastatic colorectal cancer: a pooled analysis from phase I part of two studies

IBI351（富泽拉西布）单药治疗KRAS(G12C)突变型转移性结直肠癌且既往未接受过KRAS(G12C)抑制剂治疗的中国患者的疗效和安全性：两项研究I期部分的汇总分析

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02315-7
Yuan, Ying; Deng, Yanhong; Jin, Yongdong; Guo, Zengqing; Pan, Yueyin; Wang, Cunji; Wang, Zhiwu; Hu, Yi; Hua, Dong; Meng, Xiangjiao; Zhang, Zhiye; Zhao, Mingfang; Dong, Xiaorong; Huang, Dingzhi; Li, Xiaoyan; Liu, Lian; Sun, Meili; Wang, Huijuan; Wang, Xiuwen; Yang, Nong; Zhang, Mingjun; Hu, Sheng; Wu, Dongde; Huang, Jingjing; Zhang, Sujie; Huang, Mengna; Ding, Kefeng
肿瘤
肠癌
肿瘤免疫
RAS
351
发表日期：2025
文献求助 收藏

Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation

在一项针对携带 KRAS G12C 突变的晚期实体瘤患者的 II 期临床试验中，KRAS G12C 抑制剂 Garsorasib 联合或不联合 EGFR 抗体西妥昔单抗，用于治疗结直肠癌患者。

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02274-z
Ruan, Dan-Yun; Wu, Hao-Xiang; Xu, Ye; Munster, Pamela N; Deng, Yanhong; Richardson, Gary; Yan, Dong; Lee, Myung-Ah; Lee, Keun-Wook; Pan, Hongming; Hager, Steven; Li, Xingya; Wei, Shaozhong; Hou, Xinfang; Underhill, Craig; Millward, Michael; Nordman, Ina; Zhang, Jingdong; Shan, Jianzhen; Han, Guohong; Grewal, Jaspreet; Gadgeel, Shirish M; Sanborn, Rachel E; Huh, Seok Jae; Hu, Xiaohua; Zhang, Yihong; Xiang, Ziyong; Luo, Laisheng; Xie, Xiaoxi; Shi, Zhe; Wang, Yaolin; Zhang, Ling; Wang, Feng; Xu, Rui-Hua
肿瘤
肠癌
肿瘤免疫
EGF
EGFR
RAS
发表日期：2025
文献求助 收藏